Scorpius Holdings, INC 8-K filings

Scorpius Holdings announced a significant increase in revenue and a substantial reduction in operating losses for the fourth quarter of 2023, alongside a record backlog.

NightHawk Biosciences has officially changed its name to Scorpius Holdings, reflecting its strategic shift to a pure-play biomanufacturing CDMO, and will trade under the new ticker symbol SCPX starting February 6, 2024.

NightHawk Biosciences has raised $3.25 million through the sale of non-core intellectual property and the issuance of a convertible promissory note.

NightHawk Biosciences will change its name to Scorpius Holdings, Inc. and its ticker symbol to SCPX, effective February 6, 2024, to reflect its focus on biomanufacturing.

NightHawk Biosciences has delayed its planned name change, initially scheduled for January 22, 2024, to a later, unspecified date.

NightHawk Biosciences is prioritizing its contract development and manufacturing organization (CDMO) business, Scorpius Biomanufacturing, after divesting non-core assets.

NightHawk Biosciences announces a corporate name change to Scorpius Holdings, Inc., reflecting its focus on large molecule biomanufacturing, with a corresponding ticker change to SCPX.